entity

APOE lipidation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about APOE lipidation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11Connections

6Hypotheses

6Analyses

3Outgoing

8Incoming

0Experiments

6Debates

No AI portrait yet

Outgoing (3)

Target	Relation	Type	Str
Alzheimer's Disease	involved_in	disease	0.80
Alzheimer's Disease	modulates	disease	0.80
Alzheimer'S Disease	therapeutic_target	disease	0.75

Incoming (8)

Source	Relation	Type	Str
26538644	is a key regulator of	paper	0.90
ABCA1	regulates	protein	0.90
LXRβ	modulates	protein	0.70
TREM2	regulates	gene	0.70
LXR agonists	targets	drug	0.70
R136S	enhances	gene	0.70
ABCA1	regulates	gene	0.70
LXR agonists	enhances	drug	0.70

Targeting Hypotheses (6)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A	0.763	neuroscience	APOE4-driven lipid metabolism dysregulat
TREM2-APOE Axis Manipulation via APOE Lipidation for DAM Rec	0.685	neurodegeneration	Microglial subtypes in neurodegeneration
LXRβ-Selective Agonism to Simultaneously Enhance APOE Lipida	0.668	lipidomics	Lipid metabolism dysregulation in Alzhei
Upstream restoration of glial lipid efflux and apoE lipidati	0.584	molecular-biology	Does APOE4's reduced lipid-binding direc
CYP2J2-Generated DHA Epoxides Enhance LXRβ-Mediated APOE Lip	0.380	lipidomics	Lipid metabolism dysregulation in Alzhei

APOE Lipidation Enhancement via ABCA1 Superactivation	0.000	-	Lipid metabolism dysregulation and membr

Mentioning Analyses (6)

Scientific analyses that reference this entity

Does APOE4 drive tau propagation

neurodegeneration | 2026-04-15 | 0 hypotheses

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.811

What molecular mechanisms underlie the dose-dependent protective effects of the

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.659

What specific gene expression signatures in aging mouse brain predict human AD v

neurodegeneration | 2026-04-12 | 0 hypotheses

Does structural 'normalization' of APOE4 domain interactions actually improve am

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (6)

Multi-agent debates referencing this entity

APOE4 is the strongest genetic risk factor for late-onset AD. How APOE4 specific

closed · Rounds: 4 · Score: 0.78 · 2026-04-22

The debate assumed that correcting APOE4's aberrant domain interactions would re

closed · Rounds: 4 · Score: 0.43 · 2026-04-20

The debate was structured to identify aging-neurodegeneration mechanisms using A

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Does APOE4 drive tau propagation [TARGET_ARTIFACT type=hypothesis id=TEST-123]

closed · Rounds: 4 · Score: 0.64 · 2026-04-16

Despite the debate focusing on SEA-AD transcriptomic data, no actual gene expres

closed · Rounds: 4 · Score: 0.76 · 2026-04-16

The study shows homozygous R136S fully rescues APOE4-driven pathology while hete

closed · Rounds: 4 · Score: 0.81 · 2026-04-14

Related Research

Hypotheses and analyses mentioning APOE lipidation in their description or question text

APOE Lipidation Enhancement via ABCA1 Superactivation

Score: 0.000 · unknown disease · 2026-04-28

Development of novel ABCA1 positive allosteric modulators to enhance APOE lipidation efficiency and restore functional H